| Effects on coagulation of levonorgestrel-and desogestrel-containing low dose oral contraceptives: a cross-over study S Middeldorp, JCM Meijers, AE van den Ende, A van Enk, BN Bouma, ... Thrombosis and haemostasis 84 (07), 4-8, 2000 | 273 | 2000 |
| Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells K Egan, D Crowley, P Smyth, S O'Toole, C Spillane, C Martin, ... PloS one 6 (10), e26125, 2011 | 218 | 2011 |
| Blood coagulation LA Norris Best Practice & Research Clinical Obstetrics & Gynaecology 17 (3), 369-383, 2003 | 218 | 2003 |
| Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies JR Higgins, JJ Walshe, MRN Darling, L Norris, J Bonnar American journal of obstetrics and gynecology 179 (2), 520-526, 1998 | 117 | 1998 |
| Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia LA Norris, JR Higgins, MRN Darling, JJ Walshe, J Bonnar Obstetrics & Gynecology 93 (6), 958-963, 1999 | 115 | 1999 |
| Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival FA Saadeh, L Norris, S O’Toole, N Gleeson European Journal of Obstetrics & Gynecology and Reproductive Biology 170 (1 …, 2013 | 107 | 2013 |
| Tinzaparin sodium for thrombosis treatment and prevention during pregnancy MP Smith, LA Norris, PJ Steer, GF Savidge, J Bonnar American journal of obstetrics and gynecology 190 (2), 495-501, 2004 | 102 | 2004 |
| The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives LA Norris, J Bonnar BJOG: An International Journal of Obstetrics & Gynaecology 103 (3), 261-267, 1996 | 95 | 1996 |
| A novel serum microRNA panel to discriminate benign from malignant ovarian disease R Langhe, L Norris, FA Saadeh, G Blackshields, R Varley, A Harrison, ... Cancer letters 356 (2), 628-636, 2015 | 93 | 2015 |
| Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? MP Ward, L E Kane, L A Norris, BM Mohamed, T Kelly, M Bates, A Clarke, ... Molecular cancer 20, 1-17, 2021 | 83 | 2021 |
| 9 Haemostatic changes and the oral contraceptive pill LA Norris, J Bonnar Baillière's clinical obstetrics and gynaecology 11 (3), 545-564, 1997 | 77 | 1997 |
| Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer-relationship with venous thrombosis risk FA Saadeh, L Norris, S O’Toole, BM Mohamed, R Langhe, J O’Leary, ... Thrombosis research 132 (5), 627-634, 2013 | 69 | 2013 |
| Inherited thrombophilia and pregnancy: the obstetric perspective. J Bonnar, R Green, L Norris Seminars in thrombosis and hemostasis 24, 49-53, 1998 | 65 | 1998 |
| Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? JF Brosnan, BL Sheppard, LA Norris Thrombosis and haemostasis 97 (04), 558-565, 2007 | 63 | 2007 |
| Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy LA Norris, J Bonnar, MP Smith, PJ Steer, G Savidge Thrombosis and haemostasis 92 (10), 791-796, 2004 | 62 | 2004 |
| Whole blood platelet aggregation in moderate and severe pre‐eclampsia LA Norris, N Gleeson, BL Sheppard, J Bonnar BJOG: An International Journal of Obstetrics & Gynaecology 100 (7), 684-688, 1993 | 60 | 1993 |
| Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation LA Norris, BL Sheppard, G Burke, J Bonnar BJOG: An International Journal of Obstetrics & Gynaecology 101 (3), 209-214, 1994 | 55 | 1994 |
| Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy LA Norris, M Joyce, N O'Keeffe, BL Sheppard, J Bonnar Maturitas 43 (2), 125-133, 2002 | 45 | 2002 |
| Pre-treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening A Laios, BM Mohamed, L Kelly, R Flavin, S Finn, L McEvoy, M Gallagher, ... International journal of molecular sciences 14 (1), 2085-2103, 2013 | 32 | 2013 |
| Pre-treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening A Laios, BM Mohamed, L Kelly, R Flavin, S Finn, L McEvoy, M Gallagher, ... International journal of molecular sciences 14 (1), 2085-2103, 2013 | 32 | 2013 |
Noreen GleesonAssociate Professor of Gynaecology, Trinity College DublinVerified email at dubgyn.org
